1
|
Trippodo NC and Frohlic ED: Similarities
of genetic (spontaneous) hypertension. Man and rat Circ Res.
48:309–319. 1981. View Article : Google Scholar : PubMed/NCBI
|
2
|
Okamoto K and Aoki K: Development of a
strain of spontaneously hypertensive rats. Jpn Circ J. 27:282–293.
1963. View Article : Google Scholar : PubMed/NCBI
|
3
|
Klingbeil AU, Schneider M, Martus P, et
al: A meta-analysis of the effects of treatment on left ventricular
mass in essential hypertension. Am J Med. 115:41–46. 2003.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Ménard J, Campbell DJ, Azizi M and
Gonzales MF: Synergistic effects of ACE inhibition and Ang II
antagonism on blood pressure, cardiac weight, and renin in
spontaneously hypertensive rats. Circulation. 96:3072–3078.
1997.PubMed/NCBI
|
5
|
Hosomi N, Mizushige K and Ohyama H:
Angiotensin-converting enzyme inhibition with enalapril slows
progressive intima-media thickening of the common carotid artery in
patients with non-insulin-dependent diabetes mellitus. Stroke.
32:1539–1545. 2001. View Article : Google Scholar
|
6
|
Croom KF and Wellington K: A Review of the
use of modified-release formulations in the treatment of
hypertension and angina pectoris. Drugs. 66:497–528.
2006.PubMed/NCBI
|
7
|
Ueng KC, Lin MC, Chan KC and Lin CS:
Nifedipine gastrointestinal therapeutic system: an overview of its
antiatherosclerotic effects. Expert Opin Drug Metab Toxicol.
3:769–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tostes JM: Effects of hypertension on
abdominal wall healing: experimental study in rats. Surg Today.
37:215–219. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yono M, Yamamoto Y, Yoshida M, Ueda S, et
al: Effects of doxazosin on blood flow and mRNA expression of
nitric oxide synthase in the spontaneously hypertensive rat
genitourinary tract. Life Sciences. 81:218–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Spijkers LJ, Janssen BJ, Nelissen J, et
al: Antihypertensive treatment differentially affects vascular
sphingolipid biology in spontaneously hypertensive rats. PLoS One.
6:e292222011. View Article : Google Scholar
|
11
|
Sul D, Kim H, Oh E, Phark S, et al: Gene
expression profiling in lung tissues from rats exposed to
formaldehyde. Arch Toxicol. 81:589–597. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Touyz RM and Schiffrin EL: Reactive oxygen
species in vascular biology: implications in hypertension.
Histochem Cell Biol. 122:339–352. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ruef J, Hu ZY, Yin LY, Wu Y, et al:
Induction of vascular endothelial growth factor in balloon-injured
baboon arteries. Circ Res. 81:24–33. 1997. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chua CC, Hamdy RC and Chua BH:
Upregulation of vascular endothelial growth factor by
H2O2 in rat heart endothelial cells. Free
Radic Biol Med. 25:891–897. 1998. View Article : Google Scholar : PubMed/NCBI
|
15
|
Cohuet G and Struijker-Boudier H:
Mechanisms of target organ damage caused by hypertension:
therapeutic potential. Pharmacol Ther. 111:81–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mancia G, De Backer G, Dominiczak A,
Cifkova R, et al: 2007 guidelines for the management of arterial
hypertension: the Task Force for the Management of Arterial
Hypertension of the European Society of Hypertension (ESH) and of
the European Society of Cardiology (ESC). Eur Heart J.
28:1462–1536. 2007.
|
17
|
Lugo-Baruqui A, Muñoz-Valle JF,
Arévalo-Gallegos S, et al: Role of angiotensin II in liver
fibrosis-induced portal hypertension and therapeutic implications.
Hepatol Res. 40:95–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Okuda T, Sumiya T, Mizutani K, et al:
Analyses of differential gene expression in genetic hypertensive
rats by microarray. Hypertens Res. 25:249–255. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yono M, Yoshida M, Yamamoto Y, et al:
Identification of potential therapeutic targets in
hypertension-associated bladder dysfunction. BJU Int. 105:877–883.
2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu J, Sukhova GK, Sun JS, Xu WH, et al:
Lysosomal cysteine proteases in atherosclerosis. Arterioscler
Thromb Vasc Biol. 24:1359–1366. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sevenich L, Schurigt U, Sachse K, Gajda M,
et al: Synergistic antitumor effects of combined cathepsin B and
cathepsin Z deficiencies on breast cancer progression and
metastasis in mice. Proc Natl Acad Sci USA. 107:2497–2502. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Chapman HA, Riese RJ and Shi GP: Emerging
roles for cysteine proteases in human biology. Annu Rev Physiol.
59:63–88. 1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Nägler DK, Storer AC, Portaro FC, Carmona
E, et al: Major increase in endopeptidase activity of human
cathepsin B upon removal of occluding loop contacts. Biochemistry.
36:12608–12615. 1997.PubMed/NCBI
|
24
|
Krueger S, Kalinski T, Hundertmark T, Wex
T, et al: Upregulation of cathepsin X in Helicobacter pylori
gastritis and gastric cancer. J Pathol. 207:32–42. 2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang J, Chen L, Li Y and Guan XY:
Overexpression of cathepsin Z contributes to tumor metastasis by
inducing epithelial-mesenchymal transition in hepatocellular
carcinoma. PLoS One. 6:e249672001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Castle A and Castle D: Ubiquitously
expressed secretory carrier membrane proteins (SCAMPs) 1–4 mark
different pathways and exhibit limited constitutive trafficking to
and from the cell surface. J Cell Sci. 118:3769–3780. 2005.
|
27
|
Fernández-Chacón R and Südhof TC: Novel
SCAMPs lacking NPF repeats: ubiquitous and synaptic
vesicle-specific forms implicate SCAMPs in multiple
membrane-trafficking functions. J Neurosci. 20:7941–7950.
2000.PubMed/NCBI
|
28
|
Fernández-Chacón R, Achiriloaie M, Janz R,
et al: SCAMP1 function in endocytosis. J Biol Chem.
275:12752–12756. 2000.
|
29
|
Guo Z, Liu L, Cafiso D and Castle D:
Perturbation of a very late step of regulated exocytosis by a
secretory carrier membrane protein (SCAMP2)-derived peptide. J Biol
Chem. 277:35357–35363. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liao H, Ellena J, Liu L, Szabo G, et al:
Secretory carrier membrane protein SCAMP2 and phosphatidylinositol
4,5-bisphosphate interactions in the regulation of dense core
vesicle exocytosis. Biochemistry. 46:10909–10920. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Müller HK, Wiborg O and Haase J:
Subcellular redistribution of the serotonin transporter by
secretory carrier membrane protein 2. J Biol Chem. 281:28901–28909.
2006.PubMed/NCBI
|
32
|
MacLean MR, Deuchar GA, Hicks MN, et al:
Overexpression of the 5-hydroxytryptamine transporter gene: effect
on pulmonary hemodynamics and hypoxia-induced pulmonary
hypertension. Circulation. 109:2150–2155. 2004. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sainz-Perez A, Gary-Gouy H, Gaudin F, et
al: IL-24 induces apoptosis of chronic lymphocytic leukemia B cells
engaged into the cell cycle through dephosphorylation of STAT3 and
stabilization of p53 expression. J Immunol. 181:6051–6060. 2008.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Lebedeva IV, Emdad L, Su ZZ, Gupta P, et
al: mda-7/IL-24, novel anticancer cytokine: Focus on bystander
antitumor, radiosensitization and antiangiogenic properties and
overview of the phase I clinical experience (Review). Int J Oncol.
31:985–1007. 2007.
|
35
|
Chen J, Chada S, Mhashilkar A and Miano
JM: Tumor suppressor MDA-7/IL-24 selectively inhibits vascular
smooth muscle cell growth and migration. Mol Ther. 8:220–229. 2003.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Ross JS, Stagliano NE, Donovan MJ,
Breitbart RE, et al: Atherosclerosis: a cancer of the blood
vessels? Am J Clin Pathol. 116(Suppl): S97–S107. 2001.PubMed/NCBI
|
37
|
Rao GN and Berk BC: Active oxygen species
stimulate vascular smooth muscle cell growth and proto-oncogene
expression. Circ Res. 70:593–599. 1992. View Article : Google Scholar : PubMed/NCBI
|
38
|
Li WG, Miller FJ Jr, Zhang HJ, Spitz DR,
et al: Active oxygen species stimulate vascular smooth muscle cell
growth and proto-oncogene expression. J Biol Chem. 276:29251–29256.
2001.
|